Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
Clinician,Rituximab,For use in the treatment of people with Class IV(a) lupus nephritis as part of the induction phase of therapy (expanded SA indication),Rituximab (Riximyo),Community and Hospital,Genito-Urinary System
